Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation

J. M. Kwakkel-van Erp, E. A. van de Graaf, G. D. Nossent, W. G. J. van Ginkel, D. A. van Kessel, J. M. M. van den Bosch, H. G. Otten (Utrecht, Nieuwegein, Netherlands)

Source: Annual Congress 2007 - New insights into clinical lung transplantation
Session: New insights into clinical lung transplantation
Session type: Electronic Poster Discussion
Number: 327

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. M. Kwakkel-van Erp, E. A. van de Graaf, G. D. Nossent, W. G. J. van Ginkel, D. A. van Kessel, J. M. M. van den Bosch, H. G. Otten (Utrecht, Nieuwegein, Netherlands). Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation. Eur Respir J 2007; 30: Suppl. 51, 327

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome
Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017
Year: 2018



Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction
Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019
Year: 2019



Intragraft donor-specific antibodies and lung transplantation
Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019
Year: 2019



Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017
Year: 2017



The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome
Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020
Year: 2021



Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD)
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

Significance of anti-HLA immunization in lung transplantation
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011


The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


Late-breaking abstract: Non specific IgG replacement in lung transplantation recipients with low IgG plasma levels: Effects on survival and bronchiolitis obliterans syndrome occurrence
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011

Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

TNFα-308 polymorphism associates with acute lung allograft rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 175s
Year: 2005

Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011

Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016